Luigi Bubacco
Affiliations: | University of Padua (Italy) |
Area:
neurodegenerationGoogle:
"Luigi Bubacco"Mean distance: (not calculated yet)
Collaborators
Sign in to add collaborator| Mark R. Cookson | collaborator | ||
| Michele Morari | collaborator | (FlyTree) | |
| Jennifer R. Morgan | collaborator |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Brady EB, McQuillan M, Medeiros AT, et al. (2023) Hsc70 rescues the synaptic vesicle trafficking defects caused by α-synuclein dimers. Micropublication Biology. 2023 |
| Filippini A, Mutti V, Faustini G, et al. (2020) Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytes. Glia |
| Sulzer D, Antonini A, Leta V, et al. (2020) COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside. Npj Parkinson's Disease. 6: 18 |
| Moretti P, Mariani P, Ortore MG, et al. (2020) Comprehensive Structural and Thermodynamic Analysis of Pre-Fibrillar WT α-Synuclein and its G51D, E46K and A53T Mutants by a Combination of Small-Angle X-Ray Scattering and Variational Bayesian Weighting. Journal of Chemical Information and Modeling |
| Munari F, Barracchia CG, Parolini F, et al. (2020) Semisynthetic Modification of Tau Protein with Di-Ubiquitin Chains for Aggregation Studies. International Journal of Molecular Sciences. 21 |
| Barracchia CG, Tira R, Parolini F, et al. (2020) Unsaturated Fatty Acid-Induced Conformational Transitions and Aggregation of the Repeat Domain of Tau. Molecules (Basel, Switzerland). 25 |
| Antonini A, Bravi D, Sandre M, et al. (2020) Immunization therapies for Parkinson's disease: state of the art and considerations for future clinical trials. Expert Opinion On Investigational Drugs |
| Bellucci A, Bubacco L, Longhena F, et al. (2020) Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson's Disease. Frontiers in Aging Neuroscience. 12: 68 |
| Munari F, Barracchia CG, Franchin C, et al. (2020) Semisynthetic and enzyme-mediated conjugate preparations illuminate the ubiquitination-dependent aggregation of protein tau. Angewandte Chemie (International Ed. in English) |
| Masato A, Plotegher N, Boassa D, et al. (2019) Impaired dopamine metabolism in Parkinson's disease pathogenesis. Molecular Neurodegeneration. 14: 35 |